Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Overcome low yield and high purification costs in vilanterol synthesis. New succinic acid salt method achieves 76% yield, 99.6% purity, and <0.1% S-isomer. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve high-cost, low-yield issues in minodronic acid synthesis. New halogenation-Grignard method offers 83-88% yield, no toxic reagents, and scalable production for osteoporosis drugs.
Solve supply chain risks for this key API intermediate with a 3-step industrial synthesis. 100% yield in first step, 51.3% in final step. Contact for GMP production.
Solve 5-maleimide chromone synthesis challenges with air-stable, high-yield ruthenium catalysis. Reduce costs & scale efficiently for drug development.
Solve low-yield challenges in alpha-vinyl azide production. This patent-validated method offers 80%+ yield, broad substrate scope, and scalable manufacturing for pharma R&D and procurement teams.
Discover how novel axial chiral phosphine-ene ligands enable high-yield, enantioselective allyl substitutions with simplified manufacturing for pharma R&D and production.
Discover how large steric hindrance chiral quaternary ammonium salt catalysts boost enantioselectivity in alpha-hydroxy-beta-keto ester synthesis, reducing production costs and supply chain risks for pharmaceutical manufacturers.
Discover metal-free, high-yield 3-selenofuran synthesis using visible light. Eliminate transition metals, reduce costs, and ensure supply chain stability for pharmaceutical intermediates.
Solve low enantioselectivity in alpha-hydroxy-beta-keto ester synthesis. Our CDMO expertise scales this patent-protected catalyst for 87% ee, reducing R&D costs and supply chain risks. Contact for custom synthesis.
Discover catalyst-free, ethanol-based synthesis of 3,4-dihydro-3-(2-hydroxybenzoyl)-2(1H)-quinolinone with 70-80% yield. Reduce costs and supply chain risks for API manufacturing.
Solve low-yield quinoline synthesis challenges with this silver triflate method. Achieve 94%+ yields, 99.9% purity, and simplified purification for drug development.
Solve high-cost synthesis challenges of trifluoromethyl chromonoquinolines. Our CDMO expertise delivers scalable, high-yield routes with 99%+ purity for drug development.
Solve pyrrole synthesis challenges with air-tolerant IBX oxidation. Achieve 84-92% yields, lower costs, and >99% purity for pharmaceutical intermediates. Contact us for scalable production.
Solve low-yield synthesis challenges of 2-hydroxy-indole-3-ketone with this new copper-catalyzed method. Achieve 70-80% yields, avoid expensive intermediates, and ensure supply chain stability for your drug development.
Solve 2-alkyl quinoline synthesis challenges: 80-92% yield, no anhydrous/oxygen-free, cheap catalysts. Scale with CDMO expertise.
Reduce synthesis costs and improve yield with high-functional group tolerance for API production. Scalable C-H activation method for pharmaceutical intermediates.
Eliminate thiol odor risks and catalyst poisoning in thioester production with this scalable carbonylation method. Achieve 55-78% yields using commercial reagents for stable API synthesis.
Solve 3-arylsulfonyl indole synthesis challenges with metal-free, high-yield routes. Reduce costs, avoid metal residues, and ensure supply stability for oncology drug development.
Solve high-toxicity reagent risks and multi-step costs in pyridine intermediate synthesis. New one-step method boosts yield to 87.5% with 97.5% purity, reducing solvent use and scaling challenges.
Discover efficient, low-cost synthesis of azacycle-derived polyarylmethane antitumor compounds with >80% yield. Ideal for pharma R&D and production scale-up. Contact us for custom synthesis.